Efficacy and Safety of Alirocumab in Statin-Intolerant Patients Over 3 Years: Open-Label Extension of the ODYSSEY ALTERNATIVE Trial

CIRCULATION(2018)

引用 1|浏览17
暂无评分
关键词
PCSK9,Cholesterol-lowering drugs,Efficacy,Safety,Statins
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要